118 related articles for article (PubMed ID: 38334167)
1. Evaluation of a scoring system for vein suitability in platelet apheresis donors.
Noushad S; Basavarajegowda A; Toora E; Sahoo D; Hari Priya KM
J Clin Apher; 2024 Feb; 39(1):e22106. PubMed ID: 38334167
[TBL] [Abstract][Full Text] [Related]
2. Adopting a vein assessment tool improves procedural outcomes in double dose platelet collections - A prospective study.
Augustine M; Murugesan M; Nayanar SK; Padmanabhan M
Transfus Apher Sci; 2021 Oct; 60(5):103198. PubMed ID: 34187772
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a tool to score donor vein suitability for blood donation.
Hirani R; O'Donovan J; Knight E; Bell B; Mondy P
Vox Sang; 2019 Aug; 114(6):588-594. PubMed ID: 31273797
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a sterile surgical skin marker to indicate the optimal vein for venepuncture in the blood donation setting.
Bell B; O'Donovan J; Wright ST; Gemelli CN; Knight E; Hirani R
Vox Sang; 2020 Jul; 115(5):377-387. PubMed ID: 32124456
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of donor factors contributing to plateletpheresis yields among apheresis platelet donors.
Woodall WJ; Nguyen VQ; Tran MH
J Clin Apher; 2014 Jun; 29(3):139-47. PubMed ID: 24222645
[TBL] [Abstract][Full Text] [Related]
6. Plateletpheresis donor deferral patterns at a tertiary care hospital in North India: A need for rethink of haemoglobin cutoff.
Sharma H; Khajuria K; Bansal N; Thakur K; Sharma A
Transfus Clin Biol; 2023 May; 30(2):268-271. PubMed ID: 36893913
[TBL] [Abstract][Full Text] [Related]
7. Clinical Indications and Adverse Reactions of Platelet Apheresis.
Amanat ST; Shakoor HA; Raza M; Khan N; Rauf A
J Coll Physicians Surg Pak; 2015 Jun; 25(6):403-6. PubMed ID: 26100990
[TBL] [Abstract][Full Text] [Related]
8. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
[TBL] [Abstract][Full Text] [Related]
9. Changes in hematological parameters post plateletpheresis: Single center study from North India.
Rajput S; Makroo RN; Chowdhry M; Thakur UK
Transfus Apher Sci; 2021 Dec; 60(6):103283. PubMed ID: 34625349
[TBL] [Abstract][Full Text] [Related]
10. Frequency of adverse events in plateletpheresis donors in regional transfusion centre in North India.
Patidar GK; Sharma RR; Marwaha N
Transfus Apher Sci; 2013 Oct; 49(2):244-8. PubMed ID: 23830186
[TBL] [Abstract][Full Text] [Related]
11. Pre- and post- donation haematological values in healthy donors undergoing plateletpheresis with five different systems.
Das SS; Chaudhary R; Verma SK; Ojha S; Khetan D
Blood Transfus; 2009 Jul; 7(3):188-92. PubMed ID: 19657482
[TBL] [Abstract][Full Text] [Related]
12. Delayed adverse events in male plateletpheresis donors: Initial insights on donor safety.
Gupta AM; Bajpai M
J Clin Apher; 2020 Jan; 35(1):18-24. PubMed ID: 31663633
[TBL] [Abstract][Full Text] [Related]
13. Axillary vein thrombosis in a healthy donor following platelet apheresis.
Jones DA; Williams E; Riley SA; Makris M
Br J Haematol; 2002 Feb; 116(2):390-1. PubMed ID: 11841443
[TBL] [Abstract][Full Text] [Related]
14. Switching iron-deficient whole blood donors to plateletpheresis.
O'Meara A; Infanti L; Sigle J; Stern M; Buser A
Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of platelet parameters in healthy apheresis donors using the ADVIA 120.
Ifran A; Haşimi A; Kaptan K; Nevruz O; Beyan C; Erbil K
Transfus Apher Sci; 2005 Oct; 33(2):87-90. PubMed ID: 16139569
[TBL] [Abstract][Full Text] [Related]
16. Does plateletpheresis induce a hypercoagulable state? A global assessment of donor's hemostatic system by ROTEM.
Akay OM; Taştekin F; Çolak E
Platelets; 2019; 30(8):989-993. PubMed ID: 30497323
[TBL] [Abstract][Full Text] [Related]
17. Knowledge and attitudes of apheresis donors regarding apheresis blood donation.
Tarlabelen Karaytuğ E; Boyraz S
Transfus Med; 2023 Feb; 33(1):39-48. PubMed ID: 35633143
[TBL] [Abstract][Full Text] [Related]
18. Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques.
Webley W; Stuart E; Cirino F; Cahill F; Stec T; Andrzejewski C
J Clin Apher; 2006 Oct; 21(3):195-201. PubMed ID: 16570261
[TBL] [Abstract][Full Text] [Related]
19. Alarmed or unalarmed!! Donor red cell lysis during plateletpheresis procedure.
Kaur D; Kandwal M
Transfus Apher Sci; 2018 Apr; 57(2):277-280. PubMed ID: 29610044
[TBL] [Abstract][Full Text] [Related]
20. Implications of a switch to a 100% apheresis platelet supply for patients and for blood donors: a risk benefit analysis.
Thiele T; Alt-Mayer T; Greinacher A; Bux J
Vox Sang; 2016 Nov; 111(4):350-356. PubMed ID: 27432635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
